Up a level |
Freyne, BJ ORCID: 0000-0002-9542-1582, Donath, Susan, Germano, Susan, Gardiner, Kaya, Casalaz, Dan, Robins-Browne, Roy M, Amenyogbe, Nelly, Messina, Nicole L, Netea, Mihai G, Flanagan, Katie L et al (show 2 more authors)
(2018)
Neonatal BCG Vaccination Influences Cytokine Responses to Toll-like Receptor Ligands and Heterologous Antigens.
Journal of Infectious Diseases, 217 (11).
pp. 1798-1808.
Freyne, Bridget ORCID: 0000-0002-9542-1582, Messina, Nicole, Germano, Susan, Bonnicci, Rhiain, Donath, Susan, Gardiner, Kaya, CAsalaz, Dan, Robins-Browne, Roy, Netea, Mihai, Flanagan, Katherine et al (show 2 more authors)
(2020)
Neonatal BCG vaccination reduces interferon gamma responsiveness to heterologous pathogens in infants from a randomised controlled trial.
Journal of Infectious Diseases, 221 (12).
pp. 1999-2009.
Freyne, Bridget ORCID: 0000-0002-9542-1582, Messina, Nicole, Gardiner, Kaya, Donath, Susan, Flanagan, Katie, Ponsonby, AL, Abruzzo, V, Morrison, C, Germano, Susan, Zufferey, Christel et al (show 6 more authors)
(2019)
Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting.
BMJ Open, 9 (12).
e032844-.